Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Choline salicylate+glycerol 20%/12.6% ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choline salicylate |
Inferred relationship |
Some |
|
Product containing choline salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
1 |
Choline salicylate 870mg/5ml liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choline salicylate |
Inferred relationship |
Some |
|
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oral gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choline salicylate |
Inferred relationship |
Some |
|
Product containing choline salicylate and glycerol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
1 |
Choline salicylate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
1 |
Choline salicylate-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
1 |
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oral gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Choline salicylate |
Inferred relationship |
Some |
1 |
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oral gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Choline salicylate |
Inferred relationship |
Some |
1 |
Choline salicylate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
1 |
Choline salicylate and glycerol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
1 |
Choline salicylate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
1 |
Choline salicylate only product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
1 |
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Choline salicylate |
Inferred relationship |
Some |
1 |
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Choline salicylate |
Inferred relationship |
Some |
1 |
Product containing only choline salicylate in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
1 |
Product containing choline salicylate in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
1 |
Cetalkonium chloride 100 microgram/g and choline salicylate 87.14 mg/g oromucosal gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Choline salicylate |
Inferred relationship |
Some |
2 |
Cetalkonium chloride 100 microgram/g and choline salicylate 87.14 mg/g oromucosal gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Choline salicylate |
Inferred relationship |
Some |
2 |
Product containing cetalkonium and choline salicylate in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
2 |
Cetalkonium and choline salicylate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
2 |
Cetalkonium- and choline salicylate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
2 |
Cetalkonium and choline salicylate only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Some |
2 |